AbbVie Inc. (ABBV) Social Stream
ABBVIE INC (ABBV) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ABBV.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 13 | $140 | $118 | $128 | $142.72 | -10.31% |
| 2021-11-23 | 12 | $172 | $118 | $133.083 | $142.72 | -6.75% |
| 2022-01-03 | 13 | $172 | $118 | $135.538 | $142.72 | -5.03% |
| 2022-01-05 | 13 | $172 | $118 | $140.923 | $142.72 | -1.26% |
| 2022-01-14 | 13 | $172 | $118 | $143.416 | $142.72 | 0.49% |
| 2022-01-19 | 13 | $172 | $118 | $147.166 | $142.72 | 3.12% |
| 2022-02-01 | 13 | $172 | $133 | $149.916 | $142.72 | 5.04% |
| 2022-02-03 | 13 | $180 | $133 | $151.416 | $142.72 | 6.09% |
| 2022-02-14 | 13 | $180 | $133 | $153.5 | $142.72 | 7.55% |
| 2022-02-17 | 13 | $180 | $133 | $154.083 | $142.72 | 7.96% |
| 2022-03-08 | 14 | $180 | $133 | $153.538 | $142.72 | 7.58% |
| 2022-03-16 | 14 | $180 | $133 | $154.076 | $142.72 | 7.96% |
| 2022-04-06 | 13 | $192 | $133 | $159.833 | $142.72 | 11.99% |
| 2022-04-13 | 12 | $192 | $147 | $163.25 | $142.72 | 14.38% |
| 2022-04-18 | 13 | $192 | $147 | $163.25 | $142.72 | 14.38% |
| 2022-04-22 | 13 | $192 | $147 | $166.083 | $142.72 | 16.37% |
| 2022-04-29 | 13 | $192 | $147 | $167.833 | $142.72 | 17.6% |
| 2022-05-02 | 13 | $200 | $147 | $170.75 | $142.72 | 19.64% |
| 2022-05-11 | 13 | $200 | $147 | $168.846 | $142.72 | 18.31% |
| 2022-05-20 | 14 | $200 | $140 | $166.785 | $142.72 | 16.86% |
| 2022-06-09 | 15 | $200 | $140 | $165 | $142.72 | 15.61% |
| 2022-07-22 | 15 | $200 | $140 | $165.2 | $142.72 | 15.75% |
| 2022-07-29 | 14 | $200 | $140 | $165.2 | $142.72 | 15.75% |
| 2022-08-01 | 16 | $200 | $140 | $165 | $142.72 | 15.61% |
| 2022-08-24 | 15 | $200 | $140 | $163.562 | $142.72 | 14.6% |
| 2022-09-21 | 16 | $200 | $140 | $163.562 | $142.72 | 14.6% |
The Trend in the Analyst Price Target
ABBV's average price target has moved up $35.56 over the prior 46 weeks.
ABBV reports an average of 9.72% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-03 | 13 | 172 | 118 | 135.538 | 135.42 | 0.09% |
| 2022-01-05 | 13 | 172 | 118 | 140.923 | 135.87 | 3.72% |
| 2022-01-24 | 13 | 172 | 133 | 149.916 | 132.16 | 13.44% |
| 2022-04-22 | 13 | 192 | 147 | 166.083 | 154.99 | 7.16% |
| 2022-09-10 | 16 | 200 | 140 | 163.562 | 141.42 | 15.66% |
ABBV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.03 | 8 | 1 | 6 | 1 | 1 | 16 |
The Trend in the Broker Recommendations
ABBV's average broker recommendation rating worsened by 0.27 over the prior 123 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ABBVIE INC's upside potential (average analyst target price relative to current price) is higher than 354.1% of all US stocks.
- In terms of how ABBVIE INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 3298.21% of that group.
- In terms of how ABBVIE INC fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 3207.81% of that group.
- ABBV has a lower variance in analysts' estimates than -685.63% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, TECH, SGEN, and RGEN are the three stocks most similar to ABBVIE INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding ABBV using the data that counts. Try POWR Ratings for free.